Quick answer: the only GHK-Cu dosage tested with a positive result in a randomized human trial is a 2% serum applied twice daily for 12 weeks, in a small eyebrow study.[1] A 0.4% cream for leg ulcers did no better than placebo.[2] No published human study has tested GHK-Cu injections, so there is no studied injection dose or frequency.[8][5]
GHK-Cu, also called copper tripeptide-1, is a copper-binding peptide found in skincare products and, more recently, in injectable vials. It is not an FDA-approved drug. This guide lists the amounts used in published studies, explains why injection doses circulating online have no trial behind them, and covers copper limits. For background, see our GHK-Cu profile and the healing peptides hub.
GHK-Cu dosage in published studies
| Study | Who | Form and amount | Schedule | Result |
|---|---|---|---|---|
| Eyebrow trial, Thailand, 2026 | 18 adults aged 18 to 40 | 2% GHK-Cu serum on one brow | Twice daily for 12 weeks | More and thicker brow hairs than the placebo side[1] |
| Leg ulcer trial, 1992 | 86 patients with venous leg ulcers | 0.4% copper tripeptide cream | During the trial period | No better than placebo[2] |
| Laser resurfacing trial, 2006 | 13 patients who finished | GHK-Cu skin care products after CO2 laser | Assessed over 12 weeks | No objective benefit; higher patient satisfaction[3] |
| Rat knee ligament surgery, 2015 | 72 rats | Injection into the knee, 0.3 or 3 mg/mL | Once a week for 4 weeks | Short-term benefit that faded after stopping[4] |
| Human injection | None | Not studied | Not studied | No published data[8] |
The 2006 laser study does not report the GHK-Cu concentration in its abstract, so it cannot guide a product strength.[3]
Topical GHK-Cu: what the amounts mean
Topical GHK-Cu is the form with human data, but even here the evidence is thin.
- A 2025 review found a “surprising absence” of clinical studies of GHK-Cu as an anti-wrinkle ingredient, despite its wide use.[7]
- A 2026 systematic review of aesthetic uses found only 2 randomized trials among 20 studies and called for standardized formulations and dosing regimens.[11]
- Formulation matters. GHK is water-loving and unstable, which makes it hard to formulate, and methods such as microneedling may increase how much passes into the skin.[7]
In practice, product percentages vary and are not standardized. The one positive trial used a 2% serum twice a day, and the benefit was clearest at 12 weeks.[1] Results from one product do not carry over automatically to another, because a 2026 pharmaceutics review found that GHK-Cu’s chemical form and stability depend heavily on the formulation.[6] For application tips, see how to use copper peptides. For hair, see copper peptides for hair.
GHK-Cu injection dosage and frequency
There is no evidence-based injection dose.
- NPR reported in September 2026 that no published human study has shown that injecting GHK-Cu is safe and effective.[8]
- A 2026 sports medicine primer on injectable peptides found no clinical data supporting GHK-Cu for musculoskeletal problems and said dosing, frequency and duration of treatment remain unknown.[5]
- A 2026 pharmaceutics review concluded GHK-Cu should be regarded as “promising but unproven” until controlled clinical trials are done.[6]
The only injected doses in the published research we found are in animals. In rats after knee ligament surgery, weekly injections of 0.3 or 3 mg/mL into the joint improved knee looseness at 6 weeks, and only the lower concentration made the graft stiffer. By 12 weeks the differences were gone.[4] Animal doses do not convert directly into human doses.
Dosing schedules seen online, including amounts in milligrams per day and “on and off” cycles, come from sellers and users, not from trials. Dermatologists interviewed by NPR said they advise patients to hold off on injecting anything until human studies are done.[8]
Natural GHK levels are not a dose target
GHK occurs naturally in human blood. Its discoverer, the chemist Loren Pickart, found that levels are lower in older adults than in younger ones, which is the basis for many anti-aging claims.[8] That finding does not tell anyone how much to apply or inject. No study has defined a blood level of GHK-Cu that should be reached, shown that a given dose restores younger levels, or linked a blood level to a skin or health result.
The chemistry adds another layer. A 2026 pharmaceutics review found that published studies often treat GHK-Cu as one ingredient, even though its copper-binding state, stability and breakdown vary with the formulation. It also noted that most delivery studies do not measure how much loosely bound copper a product releases.[6] Two products with the same milligram label can behave differently.
Copper limits and why dose matters
Each GHK-Cu molecule carries copper, so the dose also delivers copper.
- Adults need about 900 micrograms (0.9 mg) of copper a day.[9]
- The NIH sets the tolerable upper intake for adults at 10 mg a day from food and supplements.[9]
- Chronic exposure to too much copper can cause liver damage and stomach symptoms such as pain, cramps, nausea, diarrhea and vomiting.[9]
- People with Wilson’s disease, an inherited disorder of copper handling, are at high risk of copper toxicity.[9]
Those limits apply to copper taken by mouth, which passes through the gut and liver. They cannot be applied directly to injections. One clinician told NPR he sees patients with raised liver enzymes and raised copper after injecting too much without lab checks, though other ingredients or impurities could also play a role.[8]
Converting a vial into a dose
If a clinician has prescribed a peptide in milligrams, our peptide calculator shows how to convert that to syringe units. The calculator does not make an unstudied dose safe. Product labels on unregulated vials may not match what is inside; see topical vs injectable peptides for skin for how the routes compare.
Side effects linked to dose
Topical use in the eyebrow trial caused no serious side effects or allergic reactions.[1] Injection risks include immune reactions, infections and possible copper overload.[10][8] For the full picture, see GHK-Cu side effects, and for the research overall, GHK-Cu research. If you are comparing healing peptides, BPC-157 vs GHK-Cu covers how their evidence differs.
Questions to ask a clinician or dermatologist
- Is a topical copper peptide reasonable for my skin or hair goal, and what strength?
- What evidence supports any injected dose you are suggesting?
- Should my liver tests or copper level be checked first?
- Do I have any condition, such as Wilson’s disease or liver disease, that makes copper products risky?
